These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2995650)

  • 1. CGS 9896: agonist-antagonist benzodiazepine receptor activity revealed by anxiolytic, anticonvulsant and muscle relaxation assessment in rodents.
    Bernard PS; Bennett DA; Pastor G; Yokoyama N; Liebman JM
    J Pharmacol Exp Ther; 1985 Oct; 235(1):98-105. PubMed ID: 2995650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CGS 20625, a novel pyrazolopyridine anxiolytic.
    Williams M; Bennett DA; Loo PS; Braunwalder AF; Amrick CL; Wilson DE; Thompson TN; Schmutz M; Yokoyoma N; Wasley JW
    J Pharmacol Exp Ther; 1989 Jan; 248(1):89-96. PubMed ID: 2563294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diazepam-antagonist effects of the benzodiazepine receptor ligand CGS 9895 in rodents.
    Katzman NJ; Shannon HE
    J Pharmacol Exp Ther; 1985 Dec; 235(3):589-95. PubMed ID: 3001268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CGS 8216: agonist and diazepam-antagonist effects in rodents.
    Shannon HE; Katzman NJ
    J Pharmacol Exp Ther; 1986 Oct; 239(1):166-73. PubMed ID: 3093670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrazepam: a benzodiazepine which dissociates sedation from other benzodiazepine activities. I. Psychopharmacological profile in rodents.
    Keane PE; Simiand J; Morre M; Biziere K
    J Pharmacol Exp Ther; 1988 May; 245(2):692-8. PubMed ID: 2896794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between benzodiazepine receptor occupancy and functional effects in vivo of four ligands of differing intrinsic efficacies.
    Facklam M; Schoch P; Bonetti EP; Jenck F; Martin JR; Moreau JL; Haefely WE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1113-21. PubMed ID: 1318371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ro 19-8022, a nonbenzodiazepine partial agonist at benzodiazepine receptors: neuropharmacological profile of a potential anxiolytic.
    Jenck F; Moreau JL; Bonetti EP; Martin JR; Haefely WE
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1121-7. PubMed ID: 1356150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RP 59037 and RP 60503: anxiolytic cyclopyrrolone derivatives with low sedative potential. interaction with the gamma-aminobutyric acidA/benzodiazepine receptor complex and behavioral effects in the rodent.
    Doble A; Canton T; Dreisler S; Piot O; Boireau A; Stutzmann JM; Bardone MC; Rataud J; Roux M; Roussel G
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1213-26. PubMed ID: 8103792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home cage pretreatment with diazepam: effects on subsequent conflict testing and rotorod assessment.
    Bennett DA; Amrick CL
    J Pharmacol Exp Ther; 1987 Aug; 242(2):595-9. PubMed ID: 3612553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-ethoxymethyl-7-fluoro-3-oxo-1,2,3,5-tetrahydrobenzo[4,5]imidazo[1,2a]pyridine-4-N-(2-fluorophenyl)carboxamide (RWJ-51204), a new nonbenzodiazepine anxiolytic.
    Dubinsky B; Vaidya AH; Rosenthal DI; Hochman C; Crooke JJ; DeLuca S; DeVine A; Cheo-Isaacs CT; Carter AR; Jordan AD; Reitz AB; Shank RP
    J Pharmacol Exp Ther; 2002 Nov; 303(2):777-90. PubMed ID: 12388665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent pA2 estimation of benzodiazepine receptor antagonists.
    Kunchandy J; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1986 Sep; 8(9):553-5. PubMed ID: 3022084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral pharmacological profile of CGS 19755, a competitive antagonist at N-methyl-D-aspartate receptors.
    Bennett DA; Bernard PS; Amrick CL; Wilson DE; Liebman JM; Hutchison AJ
    J Pharmacol Exp Ther; 1989 Aug; 250(2):454-60. PubMed ID: 2547931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of seizures and antiepileptic drugs on benzodiazepine receptors in rat brain.
    Mimaki T; Yabuuchi H; Laird H; Yamamura HI
    Pediatr Pharmacol (New York); 1984; 4(4):205-11. PubMed ID: 6097863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.
    Tricklebank MD; Honoré T; Iversen SD; Kemp JA; Knight AR; Marshall GR; Rupniak NM; Singh L; Tye S; Watjen F
    Br J Pharmacol; 1990 Nov; 101(3):753-61. PubMed ID: 1963808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX).
    Swedberg MD; Jacobsen P; Honoré T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1113-21. PubMed ID: 7562477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two anticonvulsant amino-pyridazine derivatives in the conflict test in rats.
    Perio A; Chambon JP; Calassi R; Heaulme M; Biziere K
    J Pharmacol Exp Ther; 1986 Nov; 239(2):542-7. PubMed ID: 3095540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral effects of flutoprazepam (KB-509) and its metabolites].
    Ueki S; Sukamoto T; Watanabe S; Yamamoto T; Kataoka Y; Shibata S; Suwandi D; Shibata K; Takano M; Sato Y
    Nihon Yakurigaku Zasshi; 1982 Jul; 80(1):15-30. PubMed ID: 6890927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil.
    Rundfeldt C; Wlaź P; Hönack D; Löscher W
    J Pharmacol Exp Ther; 1995 Nov; 275(2):693-702. PubMed ID: 7473156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A specific benzodiazepine antagonist CGS 8216 reverses the muscle relaxant effect of diazepam but not that of phenobarbitone.
    Turski WA; Schwarz M; Turski L; Sontag KH
    Eur J Pharmacol; 1984 Mar; 98(3-4):441-4. PubMed ID: 6723782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.